Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2007
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2647808A1 Antibodies against amyloid-beta peptide
10/11/2007CA2647770A1 Compositions, methods, and kits using adenosine and inosine in combination for diagnosis and treatment
10/11/2007CA2647568A1 Amylin and amylin agonists for treating psychiatric diseases and disorders
10/11/2007CA2646755A1 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
10/11/2007CA2646088A1 Novel bi-aryl amines
10/11/2007CA2645767A1 Solid oral compositions based on s-adenosyl methionine and/or nadh and process for obtaining them
10/11/2007CA2644642A1 A process for concentration of a polypeptide
10/11/2007CA2642849A1 Suppression and treatment of neuropathic pain
10/11/2007CA2632528A1 A process for concentration of a polypeptide
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
10/10/2007EP1842556A1 Therapeutic agent for attention-deficit hyperactivity disorder
10/10/2007EP1842555A1 Tolerance development inhibitor for narcotic analgesic agent
10/10/2007EP1842551A1 E-selectin for treating or preventing stroke
10/10/2007EP1842541A1 Plant components and extracts and uses thereof
10/10/2007EP1842535A1 Use of agomelatine to obtain a medication aimed at treating generalised anxiety disorder
10/10/2007EP1841757A2 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
10/10/2007EP1841746A1 Substituted 2-amino-quinazolin-4-on compoundsfor use in the treatment of cns disorders, pain, stroke, addicition and epilepsy, their preparation and use as intermediates
10/10/2007EP1841738A2 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
10/10/2007EP1841464A2 Rnai modulation of the nogo-l or nogo-r gene and uses thereof
10/10/2007EP1841460A2 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/10/2007EP1841455A1 Humanized anti-amyloid antibody
10/10/2007EP1841438A1 Methods for the treatment of lysosomal storage disorders
10/10/2007EP1841433A2 Method and composition for treating central nervous system disorders
10/10/2007EP1841423A2 Use of 1- benzyl-1- hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3 hydroxy-2-amino propionic acid amides and related compounds as analgesics
10/10/2007EP1841418A2 Glycine reuptake inhibitors for treating drug and alcohol dependence
10/10/2007EP1841417A2 Spm 927 for add-on therapy of schizophrenia
10/10/2007EP1646328B1 Treatment of dependence withdrawal
10/10/2007EP1610792B1 Calcium channel blockers comprising two benzhydril moieties
10/10/2007EP1558252B1 Substituted furo [2,3-b]pyridine derivatives
10/10/2007EP1525200B1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1454897B1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1354884B1 Cyclopenta[d]pyrazolo[1,5-a]pyrimidine compound as crf receptor antagonist
10/10/2007EP1347990B1 Peptides having inhibiting activity to nitric oxyde production
10/10/2007EP1332132B1 Enamine derivatives as cell adhesion molecules
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007CN101052718A Mutated amyloid protein
10/10/2007CN101052651A Caspase-2 inhibitors and their biological applications
10/10/2007CN101052639A Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/10/2007CN101052637A Benzimidazole derivatives and their application as cannabinoid receptor ligand i
10/10/2007CN101052421A Phospholipase enzymes c-ªå regulating and its application for controlling pain and injury effect
10/10/2007CN101052409A Methods of treating disease with random copolymers
10/10/2007CN101052389A Agent for recovery from cerebral fatigue
10/10/2007CN101050215A Spiroazacyclic compounds as monoamine receptor modulators
10/10/2007CN101050199A (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
10/10/2007CN101049507A Pitx3 gene and application of promoter
10/10/2007CN101049485A Mulberry ¿C ginger soft capsule for treating common cold, and preparation method
10/10/2007CN101049435A Method of preparing nutriment for preventing brain dementia of middle-aged persons and elderly persons
10/10/2007CN101049433A Buccal tablets of compound fresh dendrobium stem
10/10/2007CN101049367A Preparation of Chinese medicament for treating hemicrania
10/10/2007CN101049319A Composition for improving remembrance
10/10/2007CN101049311A Compound Almitrine drop pills, and preparation technique
10/10/2007CN101049310A Nerve block injection, and preparation technique
10/10/2007CN101049308A Solid dispersion containing rimonabant and polyethyleneglycol, preparation and medication application
10/10/2007CN101049290A Application of agomelatine in preparing medicine for treating generalized anxiety disorder
10/10/2007CN101049288A New preparation method for raising rate of packaging microspheres of naltrexone
10/10/2007CN101049172A Beverage of gastrodia tuber for easing head
10/10/2007CN101049153A Foodstuff of having drug effect for neurosis
10/10/2007CN100341874C Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
10/10/2007CN100341871C Organic sulfur compound containing piperidine structure, its preparation and use
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/10/2007CN100341854C Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
10/10/2007CN100341576C Adhesive patch
10/10/2007CN100341566C Use of cone shell polypeptide derivative in preparation of drug abstaining medicine
10/10/2007CN100341528C Use of manchurian tuber gourd fruit extract for preparing analgesic, anti-inflammatory and/or anti-allergic medicine
10/10/2007CN100341509C Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/10/2007CN100341504C Zolmitriptan quick-release formulation
10/10/2007CN100341499C Compsns. for improving mental concentration
10/10/2007CN100341493C Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
10/10/2007CN100341491C Film coating
10/09/2007US7279580 For prophylaxis and therapy of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279550 For therapy of immune or autoimmune diseases
10/09/2007US7279496 suitable for the prophylaxis or treatment of psychoses, schizophrenia, depression, anxiety states, dementia, in particular Alzheimer's disease and Lewy bodies dementia, neurodegenerative disorders, etc.
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279491 Phenylpiperidines and phenylpyrrolidines
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279482 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279474 example compound: [7-(2,4-dichlorophenyl)-2-methyl-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl]-(1-ethyl-propyl)amine; treatment of irritable bowel disease and inflammatory bowel disease; anxiety; depression
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279330 Method for identifying modulating compounds of neurotransmitters
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279165 Amyloid β1-6 antigen arrays
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007US7279156 Apoptotic bodies and/or apoptotic cells are in a liquid suspension along with viable cells.
10/09/2007CA2232855C Pharmaceutical formulation
10/09/2007CA2158544C Extracellular signal-regulated kinase, sequences, and methods of production and use
1 ... 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 ... 1833